(Q54370104)

28 May 2018

title

Hemodynamic effects of intravenously administered magnesium on patients with ischemic heart disease. (English)

1 reference

28 May 2018

0 references

1 reference

Rasmussen HS

1

1 reference

28 May 2018

Larsen OG

series ordinal

2

1 reference

28 May 2018

Meier K

series ordinal

3

1 reference

28 May 2018

Larsen J

series ordinal

4

1 reference

28 May 2018

publication date

1 December 1988

1 reference

28 May 2018

published in

Clinical Cardiology

1 reference

28 May 2018

volume

11

1 reference

28 May 2018

issue

12

1 reference

28 May 2018

page(s)

824-828

1 reference

28 May 2018

Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

Intravenous magnesium in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in a nondigitalized noncardiac patient

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium therapy for torsades de pointes

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium and potassium therapy in multifocal atrial tachycardia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium sulfate and digitalis-toxic arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Effect of magnesium sulfate on cardiovascular hemodynamics

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Interactions of magnesium and verapamil on tone and contractility of vascular smooth muscle

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Ca2+ coupling in vascular smooth muscle: Mg2+ and buffer effects on contractility and membrane Ca2+ movements

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium withdrawal and contraction of arterial smooth muscle: effects of EDTA, EGTA, and divalent cations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960111205

7 January 2021

Identifiers

DOI

10.1002/CLC.4960111205

1 reference

28 May 2018

1 reference

28 May 2018